Two people died and four others, including two children, suffered serious injuries after a fire broke out at a residential complex in West Bengal's Birbhum district, officials said. The blaze ...

Bolpur (West Bengal): Two people died and four others, including two children, suffered serious injuries after a fire broke out at a residential complex in West Bengal's Birbhum district ...

A biosimilar version of AbbVie’s ABBV Humira called Simlandi was approved in February 2024 and launched in May. Selarsdi, a biosimilar version of J&J’s JNJ Stelara, was approved in April 2024 ...

The success of AVT05 builds on recent approvals of other biosimilars, such as SIMLANDI and SELARSDI. ALVO closed Friday's (Jan.24, 2025) trading at $12.99 down 0.99%. TEVA closed Friday's (Jan.24 ...

For companies, maintaining a competitive advantage over the market is necessary for long-term growth. In many cases, this competitive advantage takes the form of a federal- or state-protected ...

Let's review some notable picks from our screened stocks. Overview: Pagaya Technologies Ltd. is a technology company that utilizes data science and proprietary AI-powered technology to serve ...

Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference ...

The market is also eagerly awaiting additional details on Simlandi sales figures and the progress of the TAPI divestment. Teva operates in a highly competitive pharmaceutical landscape ...

Teva Pharmaceutical Industries TEVA reported fourth-quarter 2024 adjusted earnings of 71 cents per share, which beat the Zacks Consensus Estimate of 70 cents. Adjusted earnings declined 29% year ...

Let's review some notable picks from our screened stocks. Overview: Pagaya Technologies Ltd. is a technology company that utilizes data science and proprietary AI-powered technology to serve financial ...

The market is also eagerly awaiting additional details on Simlandi sales figures and the progress of the TAPI divestment. Teva operates in a highly competitive pharmaceutical landscape, with a ...